title: Obstacles to affordable cancer treatments.
abstract: Recent regulatory and policy changes may help to improve the affordability of some high-cost cancer treatments. However, larger systemic changes are needed to address the excessive growth in spending for cancer therapies and to ensure that patients and payers receive maximum value for their health care dollars.
authors.affiliation: Division of General Medicine and Clinical Epidemiology, UNC School of Medicine, University of North Carolina at Chapel Hill; Department of Health Policy and Management, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Dusetzina@unc.edu.
authors.forename: Stacie B
authors.initials: SB
authors.lastname: Dusetzina
authors.affiliation: Department of Hematology/Oncology and Department of Pharmacy, UNC Health Care; UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Benyam
authors.initials: B
authors.lastname: Muluneh
authors.affiliation: UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill; Hematopoietic Cell Transplantation, UNC Hospitals and Clinics, Chapel Hill, North Carolina, USA.
authors.forename: Tippu
authors.initials: T
authors.lastname: Khan
authors.affiliation: UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill; Division of Hematology/Oncology, UNC School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
authors.forename: Kristy L
authors.initials: KL
authors.lastname: Richards
authors.affiliation: Department of Health Care Policy, Harvard Medical School, Cambridge, Massachusetts; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
authors.forename: Nancy L
authors.initials: NL
authors.lastname: Keating
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000627:therapeutic use; D016527:Drug Costs; D004345:Drug Industry; D017048:Health Care Costs; D006801:Humans; D006278:Medicare; D017008:Negotiating; D009369:Neoplasms / Q000188:drug therapy / Q000191:economics*; D014481:United States
chemical_list: D000970:Antineoplastic Agents